PMID- 21243294 OWN - NLM STAT- MEDLINE DCOM- 20111014 LR - 20220629 IS - 1980-5322 (Electronic) IS - 1807-5932 (Print) IS - 1807-5932 (Linking) VI - 65 IP - 11 DP - 2010 TI - The role of central mechanisms in the anti-inflammatory effect of amitriptyline on carrageenan-induced paw edema in rats. PG - 1183-7 AB - OBJECTIVE: The present study was designed to further investigate the effect of amitriptyline, a classical tricyclic antidepressant, on carrageenan-induced paw edema in rats. METHODS: First, amitriptyline was administered intraperitoneally (i.p.) at doses of 20, 40 and 80 mg kg-1, 30 min before subplantar injection of carrageenan. Second, amitriptyline was given intracerebroventriculary or intrathecally at doses of 25, 50 and 100 mug/rat, 30 min prior to carrageenan challenge. Third, the effect of adrenergic receptor antagonists such as propranolol (10 mg kg-1, i.p.), prazosin (4 mg kg-1, i.p.) and yohimbine (10 mg kg-1, i.p.) and an opioid receptor antagonist (naloxone, 4 mg kg-1, i.p.) on the anti-inflammatory effect of amitriptyline (40 mg kg-1, i.p.) was investigated. RESULTS: Our data confirm that intraperitoneally administered amitriptyline exhibits a marked anti-inflammatory effect on carrageenan-induced paw edema in rats 4 h postcarrageenan challenge (P < 0.001). Intracerebroventricular (i.c.v.) administration of amitriptyline also reduced the development of paw edema at 4 h postcarrageenan (P < 0.001), but intrathecal (i.t.) application of amitriptyline failed to alter the degree of paw swelling. Furthermore, the applied antagonists did not modify the anti-inflammatory effect of amitriptyline. CONCLUSION: These results support the view that amitriptyline has a considerable anti-inflammatory effect on carrageenan-induced paw edema in rats and suggest that at least a part of this property could be mediated through supraspinal sites. Moreover, it seems unlikely that the investigated adrenergic and opioid receptors have a significant role in this effect of amitriptyline. FAU - Hajhashemi, Valiollah AU - Hajhashemi V AD - Isfahan Pharmaceutical Sciences Research Center, School of Pharmacy and Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran. FAU - Sadeghi, Hossein AU - Sadeghi H FAU - Minaiyan, Mohsen AU - Minaiyan M FAU - Movahedian, Ahmad AU - Movahedian A FAU - Talebi, Ardeshir AU - Talebi A LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - United States TA - Clinics (Sao Paulo) JT - Clinics (Sao Paulo, Brazil) JID - 101244734 RN - 0 (Adrenergic alpha-1 Receptor Antagonists) RN - 0 (Anti-Inflammatory Agents) RN - 1806D8D52K (Amitriptyline) RN - 9000-07-1 (Carrageenan) SB - IM MH - Adrenergic alpha-1 Receptor Antagonists/*administration & dosage MH - Amitriptyline/*administration & dosage MH - Animals MH - Anti-Inflammatory Agents/*administration & dosage MH - Carrageenan MH - Edema/chemically induced/*drug therapy MH - Inflammation/chemically induced/drug therapy MH - Injections, Spinal MH - Male MH - Rats MH - Rats, Wistar PMC - PMC2999717 EDAT- 2011/01/19 06:00 MHDA- 2011/10/15 06:00 PMCR- 2010/11/01 CRDT- 2011/01/19 06:00 PHST- 2010/04/07 00:00 [received] PHST- 2010/08/26 00:00 [accepted] PHST- 2011/01/19 06:00 [entrez] PHST- 2011/01/19 06:00 [pubmed] PHST- 2011/10/15 06:00 [medline] PHST- 2010/11/01 00:00 [pmc-release] AID - S1807-5932(22)02906-4 [pii] AID - cln_65p1183 [pii] AID - 10.1590/s1807-59322010001100022 [doi] PST - ppublish SO - Clinics (Sao Paulo). 2010;65(11):1183-7. doi: 10.1590/s1807-59322010001100022.